Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial
European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-12-0293e
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2012
Authors
Publisher
Bioscientifica